Company
Syntis Bio
| Industry | clinical-stage biopharmaceutical company developing oral therapies for obesity, diabetes and rare diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Syntis Bio | Series A | 2025-07-01 |
Company
| Industry | clinical-stage biopharmaceutical company developing oral therapies for obesity, diabetes and rare diseases |
|---|
| Company | Round | Date |
|---|---|---|
| Syntis Bio | Series A | 2025-07-01 |